Carlsmed (CARL) Operating Expenses (2024 - 2026)

Carlsmed (CARL) has reported Operating Expenses for 3 consecutive years, with $25.6 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Operating Expenses rose 66.4% year-over-year to $25.6 million; the trailing twelve-month figure through Jun 2026 stood at $87.2 million (up 64.4% YoY), and the FY2025 full-year result was $68.6 million, up 55.34% from the prior year.
• Operating Expenses rose to $25.6 million in Q2 2026 per CARL's latest filing, from $21.7 million in the prior quarter.
• Across five years, Operating Expenses topped out at $25.6 million in Q2 2026 and bottomed at $10.9 million in Q2 2024.
• Historically, Operating Expenses has averaged $16.8 million across 3 years, with a median of $15.4 million in 2025.
• The widest YoY moves for Operating Expenses: up 78.53% in 2025, down 41.26% in 2025.
• Over 3 years, Operating Expenses stood at $11.7 million in 2024, then surged by 78.53% to $20.9 million in 2025, then advanced by 22.23% to $25.6 million in 2026.
• According to Business Quant data, Operating Expenses over the past three periods registered $25.6 million, $21.7 million, and $20.9 million for Q2 2026, Q1 2026, and Q4 2025 respectively.